Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

OTC PEDIATRIC DOSING "PREFERRED AND PRACTICAL BASIS" TO BE DISCUSSED

This article was originally published in The Tan Sheet

Executive Summary

OTC PEDIATRIC DOSING "PREFERRED AND PRACTICAL BASIS" TO BE DISCUSSED at a Jan. 13 meeting of the Nonprescription Drugs Advisory Committee. According to FDA, the advisory committee will be asked to address several questions related to pediatric dosing of over-the-counter products used by children under 12, including "what is the most preferred and practical basis for determining and labeling OTC systemic pediatric dosages." FDA suggested several possible ways to establish pediatric doses, including "age, weight, height, length, body surface area," or a combination of approaches.
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS083561

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel